|
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
| 13,354.00 GBX | -6.22% |
|
-3.61% | -3.16% |
| 05:14pm | Health Care Down on Rotation Out of Defensive Sectors - Health Care Roundup | DJ |
| 03:55pm | AstraZeneca Wins Pfizer Patent Battle Over Cancer Drug | MT |
| Market Cap | 295B 258B 238B 220B 418B 28,174B 425B 2,852B 1,118B 13,835B 1,108B 1,084B 47,923B | P/E 2026 * |
23.8x | P/E 2027 * | 21x |
|---|---|---|---|---|---|
| Enterprise Value | 314B 275B 254B 235B 446B 30,018B 453B 3,038B 1,191B 14,741B 1,181B 1,155B 51,061B | EV / Sales 2026 * |
4.98x | EV / Sales 2027 * | 4.6x |
| Free-Float |
96.63% | Yield 2026 * |
1.75% | Yield 2027 * | 1.85% |
Last Transcript: AstraZeneca PLC
| 1 day | -6.22% | ||
| 1 week | -3.61% | ||
| Current month | -5.29% | ||
| 1 month | -3.20% | ||
| 3 months | -12.24% | ||
| 6 months | -5.80% | ||
| Current year | -3.16% |
| 1 week | 12,388 |  | 14,566 |
| 1 month | 11,484 | | 15,126 |
| Current year | 11,232 | | 15,732 |
| 1 year | 10,178 | | 15,732 |
| 3 years | 9,461 | | 15,732 |
| 5 years | 8,029 | | 15,732 |
| 10 years | 3,996 | | 15,732 |
| Manager | Title | Age | Since |
|---|---|---|---|
Pascal Soriot
CEO | Chief Executive Officer | 66 | 2012-09-30 |
Aradhana Sarin
DFI | Director of Finance/CFO | 52 | 2021-07-31 |
Jeffrey Pott
CMP | Compliance Officer | - | 2022-12-31 |
| Director | Title | Age | Since |
|---|---|---|---|
| Director/Board Member | 70 | 1999-04-05 | |
Pascal Soriot
BRD | Director/Board Member | 66 | 2012-09-30 |
Philip Broadley
BRD | Director/Board Member | 65 | 2017-04-26 |
| Date | Insider | Type | Main position | Quantity | % Market Cap. | |
|---|---|---|---|---|---|---|
| Jun. 07 | Free | See Remarks | 1 | 0.0000% | ||
| May. 19 | Sell | See Remarks | -11,893 | 0.0008% | ||
| May. 13 | Fiscal year | Chief Executive Officer | 18,359 | 0.0012% |
| Change | 5-day change | 1-year change | 3-year change | Capi.($) | ||
|---|---|---|---|---|---|---|
 | -6.22% | -3.61% | +29.15% | +32.09% | 295B | |
| +0.09% | +0.25% | +54.65% | +168.55% | 1,084B | |
| -1.63% | -1.50% | +65.79% | +62.43% | 634B | |
| -1.12% | -4.27% | +31.10% | +85.82% | 447B | |
| +0.18% | +2.04% | +30.19% | +26.51% | 330B | |
| -1.27% | -0.56% | +27.21% | +46.39% | 285B | |
| -0.93% | -1.19% | -28.85% | -40.38% | 218B | |
| -1.19% | -2.81% | +22.63% | +61.80% | 199B | |
| -0.72% | +2.72% | +19.07% | +78.15% | 169B | |
| +0.83% | -0.29% | -5.13% | -32.03% | 137B | |
| Average | -1.21% | +2.34% | +24.58% | +48.93% | 379.69B | |
| Weighted average by Cap. | -1.05% | +2.42% | +37.37% | +80.15% |
| 2026 * | 2027 * | |
|---|---|---|
| Net sales | 63.15B 55.25B 50.95B 47.14B 89.47B 6,028B 90.97B 610B 239B 2,960B 237B 232B 10,254B | 66.78B 58.42B 53.88B 49.85B 94.61B 6,375B 96.2B 645B 253B 3,130B 251B 245B 10,843B |
| Net income | 12.44B 10.88B 10.03B 9.28B 17.62B 1,187B 17.92B 120B 47.11B 583B 46.69B 45.68B 2,020B | 13.95B 12.2B 11.25B 10.41B 19.76B 1,331B 20.09B 135B 52.82B 654B 52.36B 51.23B 2,265B |
| Net Debt | 19.32B 16.9B 15.59B 14.42B 27.38B 1,844B 27.83B 187B 73.18B 906B 72.54B 70.97B 3,137B | 11.83B 10.35B 9.54B 8.83B 16.76B 1,129B 17.04B 114B 44.8B 555B 44.41B 43.45B 1,921B |
| Date | Price | Change | Volume |
|---|---|---|---|
| 26-07-09 | GBX 13,354.00 | -6.22% | 6,460,021 |
| 26-07-08 | GBX 14,240.00 | -0.86% | 1,480,149 |
| 26-07-07 | GBX 14,364.00 | +1.87% | 1,528,247 |
| 26-07-06 | GBX 14,100.00 | -2.46% | 2,008,204 |
| 26-07-03 | GBX 14,456.00 | -0.56% | 653,264 |
Trader
This super rating is the result of a weighted average of the rankings based on the following ratings: Valuation (Composite), EPS Revisions (4 months), and Visibility (Composite). We recommend that you carefully review the associated descriptions.
Investor
This super composite rating is the result of a weighted average of the rankings based on the following ratings: Fundamentals (Composite), Valuation (Composite), EPS Revisions (1 year), and Visibility (Composite). We recommend that you carefully review the associated descriptions.
Global
This composite rating is the result of an average of the rankings based on the following ratings: Fundamentals (Composite), Valuation (Composite), Financial Estimates Revisions (Composite), Consensus (Composite) and Visibility (Composite). The company must be covered by at least 4 of these 5 ratings for the calculation to be carried out. We recommend that you carefully review the associated descriptions.
Quality
This composite rating is the result of an average of rankings based on the following ratings: Returns (Composite), Profitability (Composite) and Quality of Financial Reporting (Composite), and Financial Health (Composite). The company must be covered by at least 2 of these 3 ratings for the calculation to be performed. We recommend that you carefully read the associated descriptions.
ESG MSCI
The MSCI ESG score assesses a company’s environmental, social, and governance practices relative to its industry peers. Companies are rated from CCC (laggard) to AAA (leader). This rating helps investors incorporate sustainability risks and opportunities into their investment decisions.
Quarterly revenue - Rate of surprise
- Stock Market
- Stocks
- AZN Stock
Choose MarketScreener Select your edition
All financial news and data tailored to specific country editions
